Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 29, 2023
Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has been granted a Good Manufacturing Practice (GMP) license by the Belgian Federal Agency for Medicines and Health Products (...
read more
Ardena announced it has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, NJ.
read more
Ardena announced the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further strengthen Ardena’s executive leadership team as the company continues to scale its operations and ...
read more
Wednesday, April 15, 2026
Ardena announced that its new GLP bioanalytical laboratory in Somerset, New Jersey, is now operational and supporting client studies.
read more
Ardena announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer.
read more
Monday, September 11, 2017
A new early-phase contract development and manufacturing organization, Ardena, has launched following the merging of Pharmavize and Crystallics.
read more
Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients and intermediates for the life science industry.
read more
Tuesday, October 29, 2024
Ardena announced a substantial expansion of its Bioanalytical Services in the Netherlands. This strategic investment includes establishing a brand new bioanalytical lab at Ardena’s Pivot Park facility in Oss, along with additional capacity and new ...
read more
Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning all the development life cycle, has announced upgrades to its development and manufacturing facilities in ...
read more
Thursday, January 29, 2026
Ardena announced that it has completed the divestment of its drug substance (API) site in Södertälje, Sweden, to Nanologica AB.
read more
Tuesday, February 04, 2025
Ardena announced that it has successfully completed the acquisition of Catalent’s state-of-the-art drug product manufacturing facility in Somerset, New Jersey.
read more
Ardena announced the appointment of Paul Edwards as Chief People Officer. He will lead Ardena’s global people strategy, strengthening organizational capability and supporting the company’s continued international growth.
read more
Thursday, November 06, 2025
Ardena announced the appointment of Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer. These appointments strengthen Ardena’s executive leadership team and reflect its continued focus on quality, compliance, and ...
read more
Thursday, October 20, 2022
Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning across the development life cycle, is investing into almost trebling the size of its Swedish facility as part ...
read more
Contract development manufacturer of nanomedicines, Ardena, has joined forces with mRNA and LNP technology specialists RiboPro to form a new strategic commercial alliance aimed at delivering improvements
read more